Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 24, 2016 - Issue 1
Submit an article Journal homepage
1,222
Views
19
CrossRef citations to date
0
Altmetric
Letters to the Editor

Rituximab and Acute Retinal Necrosis in a Patient with Scleromalacia and Rheumatoid Arthritis

Sarah SchulerÓMMA Eye Center, Zurich, Switzerland and Correspondence[email protected]
, MD,
Matthias BrunnerÓMMA Eye Center, Zurich, Switzerland and
, MD &
Wolfgang BernauerÓMMA Eye Center, Zurich, Switzerland and ;University of Zurich, Zurich, Switzerland
, MD
Pages 96-98 | Received 26 Aug 2014, Accepted 14 Dec 2014, Published online: 11 Mar 2015

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Andrea Servillo, Alessandro Berni, Alessandro Marchese, Bahram Bodaghi, Moncef Khairallah, Russell W. Read & Elisabetta Miserocchi. (2023) Posterior Herpetic Uveitis: A Comprehensive Review. Ocular Immunology and Inflammation 31:7, pages 1461-1472.
Read now
Neslihan Sevimli, Remzi Karadag, Ercan Madenci, Huseyin Bayramlar, Pinar Arslan, Ayse Ocal & Yasar Dag. (2017) Ocular surface findings in patients with rheumatoid arthritis under methotrexate or biological agent therapy. Cutaneous and Ocular Toxicology 36:1, pages 48-51.
Read now
Emmett T. Cunningham$suffix/text()$suffix/text(), Peter McCluskey, Carlos Pavesio, Denis Wakefield & Manfred Zierhut. (2016) Scleritis. Ocular Immunology and Inflammation 24:1, pages 2-5.
Read now

Articles from other publishers (16)

Letícia Queiroga de Figueiredo, Fernanda Oliveira de Andrade Lopes, André Silva Franco, Henrique Ayres Mayrink Giardini, Lissiane Karine Noronha Guedes, Karina Rossi Bonfiglioli, Andrea Yukie Shimabuco, Ana Cristina de Medeiros Ribeiro & Diogo Souza Domiciano. (2023) Scleromalacia perforans as an early manifestation of late-onset rheumatoid arthritis: a case-based review. Rheumatology International.
Crossref
Christine Xu, Alisa J. Prager, Carolyn D. Alonso & Aditya S. Pawar. (2022) Insights From the Eye for Patients With Kidney Transplant. Transplantation Proceedings 54:8, pages 2182-2191.
Crossref
Yuliya Lytvyn, Shahmina Rahat, Asfandyar Mufti, Adrian Witol, Ahmed Bagit, Muskaan Sachdeva & Jensen Yeung. (2022) Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review. Journal of the American Academy of Dermatology 87:1, pages 110-120.
Crossref
Rosanna Dammacco, Silvana Guerriero, Giovanni Alessio & Franco Dammacco. (2021) Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review. International Ophthalmology 42:2, pages 689-711.
Crossref
Christine Xu, Alisa J. Prager, Carolyn D. Alonso & Aditya Pawar. (2022) Insights from the Eye for Patients with Kidney Transplant. SSRN Electronic Journal.
Crossref
Helio V. Neves da Silva, John Placide, Anne Duong, Yasmyne Ronquillo, Shannon McCabe & Majid Moshirfar. (2022) Ocular adverse effects of therapeutic biologics. Therapeutic Advances in Ophthalmology 14, pages 251584142110708.
Crossref
Caleb C. Ng, Aileen Sy & Emmett T. CunninghamJrJr. (2021) Rituximab for non-infectious Uveitis and Scleritis. Journal of Ophthalmic Inflammation and Infection 11:1.
Crossref
Veronique Promelle, Vincent Goeb & Julie Gueudry. (2021) Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives. Journal of Clinical Medicine 10:10, pages 2118.
Crossref
Clara M Castillejo Becerra, Yue Ding, Beatrice Kenol, Andrew Hendershot & Alexa Simon Meara. (2020) Ocular side effects of antirheumatic medications: a qualitative review. BMJ Open Ophthalmology 5:1, pages e000331.
Crossref
Fereshteh Ashtari, Atousa Hakamifard, Amirali Hariri & Tahereh Gholipour-shahraki. (2020) Rituximab associated necrosis: A case report. Multiple Sclerosis and Related Disorders 37, pages 101429.
Crossref
Xia Ni Wu, Sue Lightman & Oren Tomkins‐Netzer. (2019) Viral retinitis: diagnosis and management in the era of biologic immunosuppression: A review. Clinical & Experimental Ophthalmology 47:3, pages 381-395.
Crossref
W. Bernauer, S. Schuler & L. Borradori. (2018) Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid. Journal of Ophthalmic Inflammation and Infection 8:1.
Crossref
S. Jayashree, K. Nirekshana, Gunjan Guha & Dipita Bhakta-Guha. (2018) Cancer chemotherapeutics in rheumatoid arthritis: A convoluted connection. Biomedicine & Pharmacotherapy 102, pages 894-911.
Crossref
Mohit Dogra, Priya Bajgai, Ashok Kumar & Aman Sharma. (2018) Progressive outer retinal necrosis after rituximab and cyclophosphamide therapy. Indian Journal of Ophthalmology 66:4, pages 591.
Crossref
Sid A. SchechetKevin Garff, Karen KlimaWayne CampbellLisa S. Schocket. (2018) ACUTE RETINAL NECROSIS AFTER ADMINISTRATION OF ADALIMUMAB, A SYSTEMIC ANTITUMOR NECROSIS FACTOR ANTIBODY. RETINAL Cases & Brief Reports 12:4, pages 307-309.
Crossref
. (2016) Cyclophosphamide/rituximab. Reactions Weekly 1593:1, pages 66-66.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.